What has been amended
The federal government has registered the Therapeutic Goods (Manufacturing Principles) Amendment Determination 2026, formally amending the Therapeutic Goods (Manufacturing Principles) Determination 2020. The amendment was registered on 6 October 2026.
What the amendment covers
The instrument makes changes to the rules that govern how therapeutic goods - including medicines, medical devices, and similar products - are required to be manufactured in Australia. The source document does not specify the detail of what those changes are or what they require of manufacturers.
Where to find the detail
The full text of the amendment is available at the Federal Register of Legislation: https://www.legislation.gov.au/F2026L01362
An Explanatory Statement is listed as a separate document on the same page. That statement describes what the amendments do.
Key actions
- Read the full amendment at https://www.legislation.gov.au/F2026L01362 to find out what has changed.
- Read the Explanatory Statement attached to the instrument on the same page for a plain-language description of what the amendments do.
- Contact the Therapeutic Goods Administration (TGA) via https://www.tga.gov.au for clarification on how the changes relate to manufacturing licences or obligations.
This is a plain-English summary for information only, not legal or compliance advice. Always check the official source or consult a qualified professional.